JOHNS HOPKINS FAMILY PROFESSORSHIP FOR ONCOLOGY RESEARCH
Established in 2004 with leadership gifts from James E. T. Hopkins, Janie Elizabeth Bailey and her husband Michael Musgrave, and an additional 10 members of the Hopkins family, including John L. Clark, whose bequest initiated the professorship in 1998.

JAMES E.T. HOPKINS, A&S 1937, Med 1941, is the great-great nephew of Johns Hopkins. He left his surgical practice at The Johns Hopkins Hospital in 1942 to volunteer for military duty in the Pacific during World War II in the Army Medical Corps. Dr. Hopkins joined a unit that became known as Merrill's Marauders and received numerous honors, including the Bronze Star and the Presidential Unit Citation, for his efforts to provide medical care to the wounded behind enemy lines. After the war, Dr. Hopkins authored Spearhead: The Complete History of Merrill's Marauder Rangers. He retired from private thoracic surgery practice in Baltimore in 1989.

 

Image Credit: Robert J. Smith JANIE ELIZABETH (LIZA) BAILEY is the great-great-great niece of Johns Hopkins. She worked on Wall Street for 30 years, and for the last 20 years in mergers and acquisitions at Credit Suisse First Boston, from which she retired in 2004. Ms. Bailey is co-founder of GlobeVest Partners, a private equity international fund of funds. MICHAEL MUSGRAVE is a faculty member of the Julliard School of New York City, and was named an honorary fellow of the Royal College of Music. Dr. Musgrave is a leading authority on German music of the 19th and 20th centuries and has authored and edited eight books on Brahms and related subjects.

 

ROBERT A. BRODSKY, the Johns Hopkins Family Professor of Oncology Research, joined the Hopkins faculty in 1997 and now directs the Division of Hematology as well as the Hematology Fellowship Training Program. Board certified in internal medicine, hematology, and oncology, Dr. Brodsky was named a Clinical Resarch Scholar of the Leukemia and Lymphoma Society of America in 2000 and a fellow of the American College of Physicians in 2004. His clinical and laboratory interests include bone marrow failure disorders and autoimmune diseases. He and his colleagues have pioneered the use of high-dose cyclophosphamide therapy for the treatment of aplastic anemia and other autoimmune conditions. Dr. Brodsky previously held the Edythe Harris Lucas and Clara Lucas Lynn Chair in Hematology at Johns Hopkins. He has authored or co-authored nearly 40 scientific articles, and contributed book reviews and numerous book chapters, and holds a patent for detection of GPI anchored proteins.